Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen
about
Recombinant yellow fever viruses are effective therapeutic vaccines for treatment of murine experimental solid tumors and pulmonary metastases.Harnessing the Microbiome to Enhance Cancer ImmunotherapyTrypanosoma cruzi adjuvants potentiate T cell-mediated immunity induced by a NY-ESO-1 based antitumor vaccinePhotodynamic therapy of tumors can lead to development of systemic antigen-specific immune responseInduction of CD8 T cells by vaccination with recombinant adenovirus expressing human papillomavirus type 16 E5 gene reduces tumor growthProtection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.The future of interleukin-2: enhancing therapeutic anticancer vaccinesDeveloping recombinant and synthetic vaccines for the treatment of melanoma.The new vaccines: building viruses that elicit antitumor immunity.Cytokine enhancement of DNA immunization leads to effective treatment of established pulmonary metastases.Toll-like receptors in tumor immunotherapy.Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo.Dendritic cells genetically modified with an adenovirus vector encoding the cDNA for a model antigen induce protective and therapeutic antitumor immunity.Idiotypes as immunogens: facing the challenge of inducing strong therapeutic immune responses against the variable region of immunoglobulinsImmunization against endogenous retroviral tumor-associated antigens.Impact of cytokine administration on the generation of antitumor reactivity in patients with metastatic melanoma receiving a peptide vaccine.Immunizing patients with metastatic melanoma using recombinant adenoviruses encoding MART-1 or gp100 melanoma antigensProtective anti-tumor immunity induced by vaccination with recombinant adenoviruses encoding multiple tumor-associated cytotoxic T lymphocyte epitopes in a string-of-beads fashionTransfectant influenza A viruses are effective recombinant immunogens in the treatment of experimental cancerDendritic cells infected with poxviruses encoding MART-1/Melan A sensitize T lymphocytes in vitroModification to the capsid of the adenovirus vector that enhances dendritic cell infection and transgene-specific cellular immune responsesIdentification of a CD11b(+)/Gr-1(+)/CD31(+) myeloid progenitor capable of activating or suppressing CD8(+) T cells.Phase I trial of recombinant adenovirus gene transfer in lung cancer. Longitudinal study of the immune responses to transgene and viral productsPrime-Boost Immunization Eliminates Metastatic Colorectal Cancer by Producing High-Avidity Effector CD8+ T Cells.Photodynamic therapy plus regulatory T-cell depletion produces immunity against a mouse tumour that expresses a self-antigen.Human dendritic cells infected with an adenoviral vector suppress proliferation of autologous and allogeneic T cells.
P2860
Q27469314-97E91712-F724-4048-AC0F-6A7B93AAEC8FQ28088598-0831AE00-CE81-403A-BA0A-9E2DEA7B1280Q28483146-9EC7FD0E-B873-42BD-8EC3-A86F9DCFBED9Q28744245-51DD1005-EBEC-4708-9970-A720C02D5A96Q33604559-1277B996-28FE-4B00-A0DE-97B8E924BE75Q33727055-91B450BC-C59A-4008-AA3E-E56614675A3EQ33844221-4C32EE8A-76FB-402E-A3CE-4AF734AD6F91Q35946196-ADD50FED-66B5-4416-9E55-6AC54C8CDD1EQ35946203-E533EB1B-83E0-48B7-A91C-F72C5B9BA337Q36088999-1CDEA45F-D0E4-49C3-8255-477F50859438Q36253608-6EF7D420-0399-4344-B3CD-190ED8F1A5F1Q36367821-58AF0FEF-550E-4B60-96E2-D388CCB9EDF2Q36380749-DAB70014-4DC2-4704-8B8B-7DB3888B615DQ36386109-B9EE0451-485E-45CC-A986-B0E860A4B460Q36468362-FAE904AF-50D1-4FE4-9260-B66DDA0B0B8BQ36473826-0F585CF1-385D-4FB9-9F90-6B56C1757251Q36473845-264F8093-881B-4E19-AEC4-4796F4E3C59AQ36829259-CEF4BDA2-ED79-4C49-852B-31E755AFFD33Q36916492-91E73ACE-0D83-4831-B355-446DE3E02E66Q36924579-AA2E0D27-E0BC-4D18-BC1D-8BFACA7233E3Q36954135-142B4AB5-8FC0-45A6-AA76-85313A0F8FE7Q37325176-1E5F04EF-EE2B-4D78-B037-C6CCCB49EF3EQ37374242-0260F0C4-99DC-4980-8CB8-201E26E51A70Q40274361-DC236FA3-B140-43D5-9A6D-0DA97A152C17Q42683580-BB3B201A-7898-4946-A2FA-C8BDE5EEB6FAQ47677023-69BC5A28-2C47-41B5-A0A1-8B7B48B94267
P2860
Therapeutic antitumor response after immunization with a recombinant adenovirus encoding a model tumor-associated antigen
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Therapeutic antitumor response ...... model tumor-associated antigen
@ast
Therapeutic antitumor response ...... model tumor-associated antigen
@en
type
label
Therapeutic antitumor response ...... model tumor-associated antigen
@ast
Therapeutic antitumor response ...... model tumor-associated antigen
@en
prefLabel
Therapeutic antitumor response ...... model tumor-associated antigen
@ast
Therapeutic antitumor response ...... model tumor-associated antigen
@en
P2093
P2860
P1476
Therapeutic antitumor response ...... model tumor-associated antigen
@en
P2093
P2860
P304
P407
P577
1996-01-01T00:00:00Z